Ireland· IE-PA-PA23180/022/001

Buscopan Rx 10mg Coated Tablets

A butylscopolamine product containing hyoscine butylbromide, registered in Ireland by Opella Healthcare France SAS T/A Sanofi. The same ATC class is registered in 11 of our 19 countries.

ATC A03BB01

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about hyoscine butylbromideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Butylscopolamine is registered in 11 of 19 countries.

Countries holding a registration under ATC A03BB01 (butylscopolamine), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
6 of them publish a price we can compare per daily dose

Search butylscopolamine products by name

Butylscopolamine · ATC A03BB01

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)

Active substance: Hyoscine butylbromide
Manufacturer: Opella Healthcare France SAS T/A Sanofi
Country: Ireland (IE)
ATC code: A03BB01
ATC class: Butylscopolamine
Defined daily dose: 60 mg, O
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
PA23180/022/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Butylscopolamine in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All butylscopolamine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Buscapina, Buscopan
Belgium · Buscopan, Buscopan Forte
Bulgaria · Бусколизин, Бусколизин Форте
Cyprus · Avotrin, Buscopan
Czechia · Buscopan, Butylskopolaminium Bromid Kalceks
Germany · Buscopan, Buscopan Ampullen
Denmark · Bumacor
Estonia · Bysimin
Spain · Buscapina, Buscopresc
Finland · Bumacor, Buscopan
France · Buscopan, Scoburen
United Kingdom (Northern Ireland) · Almus Ibs Relief, Almus Stomach Cramp Relief
Greece · Avotrin, Buscopan
Croatia · Buscopan, Bysimin
Hungary · Buscopan, Buscopan Forte
Italy · Addofix, Buscopan
Luxembourg · Buscopan, Buscopan Forte
Latvia · Buscopan, Hyoscine Butylbromide Kalceks
Malta · Buscopan, Buscopan Ampoules
Netherlands · Buscopan, Scopolamine Butylbromide Kalceks
Norway · Bumacor, Buscopan
Poland · Aurogastro, Buscolysin
Portugal · Buscopan, Butilescopolamina Conforpam
Romania · Buscopan, Buscotil
Sweden · Bumacor, Buscopan
Slovenia · Buscopan
Slovakia · Buscopan, Scopolamine Butylbromide Kalceks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/40403f6a-1066-480f-8659-13f56589417e
GET /v1/drugs/40403f6a-1066-480f-8659-13f56589417e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "A03BB",
    "A03BB01"
  ],
  "strength": null,
  "pa_number": "PA23180/022/001",
  "substances": [
    "Hyoscine butylbromide"
  ],
  "legal_basis": "Informed consent application (Article 10c of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "02/12/2016",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about butylscopolamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console